INBX | Inhibrx, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	13.93 - 14.34
52 Week Range	10.80 - 18.95
Beta	1.31
Implied Volatility	99.74%
IV Rank	36.87%
Day's Volume	86,565
Average Volume	94,617
Shares Outstanding	14,475,904
Market Cap	203,241,692
Sector	Healthcare
Industry	Biotechnology
IPO Date	2024-06-04

Valuation
Profitability
Growth
Health
P/E Ratio	0.12
Forward P/E Ratio	N/A
EPS	119.39
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	166
Country	USA
Website	INBX

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma. The company was incorporated in 2024 and is based in La Jolla, California.

INBX's peers: ALVR, BCYC, BHVN, CLLS, CLSD, CRMD, CRNX, DBVT, ENTA, ETON, FOLD, GANX, HALO, IMTX, MRUS, LYEL, KRON, OPT, MLYS, ELYM, ANEB, MACK, CELC, ELVN, GLUE, DSGN, HOWL, IKNA, STOK, PTGX, DICE, LRMR, VRDN, IPHA, IVA, JAZZ, JSPR, MDWD, PCSA, TLSA, URGN, VALN, XENE, LIPO

*Chart delayed

Analyzing fundamentals for INBX we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is stunning wealthy, Growth is very bad and Health is very strong. For more detailed analysis please see INBX Fundamentals page.

Watching at INBX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on INBX Technicals page.